Boston Scientific
Trade Boston Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
BSX Key Statistics
BSX News
Investors in Boston Scientific Corporation ( ) had a good week, as its shares rose 6.3% to close at US$101 following the release of its quarterly results. Bosto...
Boston Scientific (BSX) announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial evaluating the use of the...
recently announced a significant change to its leadership team with the planned retirement of CFO Dan Brennan, to be succeeded by Jon Monson. Alongside this tra...
Analyst ratings
85%
of 34 ratingsMore BSX News
Boston Scientific Corporation BSX posted better-than-expected earnings for the first quarter on Wednesday. The company reported first-quarter 2025 revenues of...
Boston Scientific ( ) First Quarter 2025 Results Key Financial Results Revenue: US$4.66b (up 21% from 1Q 2024). Net income: US$672.0m (up 36% from 1Q 2024)....
Boston Scientific ( (BSX) ) has released its Q1 earnings. Here is a breakdown of the information Boston Scientific presented to its investors. Boston Scientifi...
Boston Scientific ((BSX)) has held its Q1 earnings call. Read on for the main highlights of the call. Boston Scientific’s latest earnings call reflected a gene...
BTIG analyst Marie Thibault has maintained their bullish stance on BSX stock, giving a Buy rating today. Marie Thibault’s rating is based on Boston Scientific’...
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $124 from $120 and keeps a Buy rating on the shares after the company r...
Boston Scientific Corporation BSX on Wednesday reported first-quarter 2025 revenues of $4.66 billion, beating the consensus estimate of $4.57 billion. Sales in...
